Search

Trent R. Clarke

Examiner (ID: 9262, Phone: (571)272-2904 , Office: P/1651 )

Most Active Art Unit
1651
Art Unit(s)
1651
Total Applications
507
Issued Applications
172
Pending Applications
83
Abandoned Applications
270

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 20527503 [patent_doc_number] => 12545930 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-02-10 [patent_title] => Cochlear inner hair cell promoters and uses thereof [patent_app_type] => utility [patent_app_number] => 17/734246 [patent_app_country] => US [patent_app_date] => 2022-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10443 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17734246 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/734246
Cochlear inner hair cell promoters and uses thereof May 1, 2022 Issued
Array ( [id] => 19265712 [patent_doc_number] => 20240209411 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-27 [patent_title] => METHOD FOR STERILITY TESTING [patent_app_type] => utility [patent_app_number] => 18/288304 [patent_app_country] => US [patent_app_date] => 2022-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10591 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -33 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18288304 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/288304
METHOD FOR STERILITY TESTING Apr 25, 2022 Pending
Array ( [id] => 17777799 [patent_doc_number] => 20220244148 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-04 [patent_title] => Composition and Method for Disrupting Tissue Material [patent_app_type] => utility [patent_app_number] => 17/727425 [patent_app_country] => US [patent_app_date] => 2022-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12884 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17727425 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/727425
Composition and Method for Disrupting Tissue Material Apr 21, 2022 Abandoned
Array ( [id] => 19250197 [patent_doc_number] => 20240201185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-20 [patent_title] => MARKERS OF AUTOIMMUNE DISEASES [patent_app_type] => utility [patent_app_number] => 18/556496 [patent_app_country] => US [patent_app_date] => 2022-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10254 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18556496 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/556496
MARKERS OF AUTOIMMUNE DISEASES Apr 20, 2022 Pending
Array ( [id] => 17944368 [patent_doc_number] => 20220331385 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-20 [patent_title] => ANTI-CANCER ONCOLYTIC VIRUS COMBINATION THERAPIES AND ELITE RESPONDER SELECTION PLATFORMS [patent_app_type] => utility [patent_app_number] => 17/660051 [patent_app_country] => US [patent_app_date] => 2022-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11267 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17660051 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/660051
ANTI-CANCER ONCOLYTIC VIRUS COMBINATION THERAPIES AND ELITE RESPONDER SELECTION PLATFORMS Apr 20, 2022 Abandoned
Array ( [id] => 17789899 [patent_doc_number] => 20220248990 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-11 [patent_title] => GLUCOSE DETECTING COMPLEX AND CONTACT LENS-TYPE SENSOR COMPRISING SAME FOR DETECTING GLUCOSE IN TEARS [patent_app_type] => utility [patent_app_number] => 17/725353 [patent_app_country] => US [patent_app_date] => 2022-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9244 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17725353 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/725353
GLUCOSE DETECTING COMPLEX AND CONTACT LENS-TYPE SENSOR COMPRISING SAME FOR DETECTING GLUCOSE IN TEARS Apr 19, 2022 Pending
Array ( [id] => 17749982 [patent_doc_number] => 20220228187 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-21 [patent_title] => SERUM-FREE CELL CULTURE MEDIUM [patent_app_type] => utility [patent_app_number] => 17/712697 [patent_app_country] => US [patent_app_date] => 2022-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12633 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -47 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17712697 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/712697
Serum-free cell culture medium Apr 3, 2022 Issued
Array ( [id] => 17702848 [patent_doc_number] => 20220202854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-30 [patent_title] => HUMAN FACILITATING CELLS [patent_app_type] => utility [patent_app_number] => 17/693500 [patent_app_country] => US [patent_app_date] => 2022-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14814 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17693500 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/693500
HUMAN FACILITATING CELLS Mar 13, 2022 Abandoned
Array ( [id] => 18503611 [patent_doc_number] => 11701401 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-07-18 [patent_title] => Herbal composition in powder, pill or liquid form for speeding up fracture healing and bone regeneration and herbal formulation in powder, pill or liquid form containing the same [patent_app_type] => utility [patent_app_number] => 17/692579 [patent_app_country] => US [patent_app_date] => 2022-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 5253 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17692579 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/692579
Herbal composition in powder, pill or liquid form for speeding up fracture healing and bone regeneration and herbal formulation in powder, pill or liquid form containing the same Mar 10, 2022 Issued
Array ( [id] => 17670973 [patent_doc_number] => 20220184140 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-16 [patent_title] => USE OF ADHERENT STROMAL CELLS FOR ENHANCING HEMATOPOIESIS IN A SUBJECT IN NEED THEREOF [patent_app_type] => utility [patent_app_number] => 17/687799 [patent_app_country] => US [patent_app_date] => 2022-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22310 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17687799 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/687799
USE OF ADHERENT STROMAL CELLS FOR ENHANCING HEMATOPOIESIS IN A SUBJECT IN NEED THEREOF Mar 6, 2022 Abandoned
Array ( [id] => 20375602 [patent_doc_number] => 12483047 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-11-25 [patent_title] => Compositions and methods for treating and preventing macular degeneration [patent_app_type] => utility [patent_app_number] => 17/681468 [patent_app_country] => US [patent_app_date] => 2022-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 24 [patent_no_of_words] => 17670 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17681468 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/681468
Compositions and methods for treating and preventing macular degeneration Feb 24, 2022 Issued
Array ( [id] => 19258274 [patent_doc_number] => 12018320 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-06-25 [patent_title] => Selective oxidation of 5-methylcytosine by TET-family proteins [patent_app_type] => utility [patent_app_number] => 17/675502 [patent_app_country] => US [patent_app_date] => 2022-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 89 [patent_no_of_words] => 58643 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17675502 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/675502
Selective oxidation of 5-methylcytosine by TET-family proteins Feb 17, 2022 Issued
Array ( [id] => 19556869 [patent_doc_number] => 20240368661 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-07 [patent_title] => COMPOSITIONS AND METHODS FOR PRODUCING REBAUDIOSIDE D [patent_app_type] => utility [patent_app_number] => 18/546881 [patent_app_country] => US [patent_app_date] => 2022-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 62460 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18546881 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/546881
COMPOSITIONS AND METHODS FOR PRODUCING REBAUDIOSIDE D Feb 16, 2022 Pending
Array ( [id] => 19067642 [patent_doc_number] => 20240102068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-28 [patent_title] => C-GLYCOSYLTRANSFERASE VARIANTS AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/263127 [patent_app_country] => US [patent_app_date] => 2022-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16835 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18263127 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/263127
C-GLYCOSYLTRANSFERASE VARIANTS AND USE THEREOF Jan 26, 2022 Pending
Array ( [id] => 20207483 [patent_doc_number] => 20250277203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-09-04 [patent_title] => EXPRESSION VECTORS COMPOSITION [patent_app_type] => utility [patent_app_number] => 18/265659 [patent_app_country] => US [patent_app_date] => 2021-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11456 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18265659 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/265659
EXPRESSION VECTORS COMPOSITION Dec 6, 2021 Pending
Array ( [id] => 18903043 [patent_doc_number] => 20240018528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-18 [patent_title] => A TUNABLE PHOSPHORYLATION-BASED FEEDBACK CONTROLLER OF MAMMALIAN GENE EXPRESSION [patent_app_type] => utility [patent_app_number] => 18/039583 [patent_app_country] => US [patent_app_date] => 2021-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31548 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -92 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18039583 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/039583
A TUNABLE PHOSPHORYLATION-BASED FEEDBACK CONTROLLER OF MAMMALIAN GENE EXPRESSION Dec 1, 2021 Pending
Array ( [id] => 20173181 [patent_doc_number] => 12391915 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-08-19 [patent_title] => Maintenance of differentiated cells with laminins [patent_app_type] => utility [patent_app_number] => 17/511079 [patent_app_country] => US [patent_app_date] => 2021-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 3838 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17511079 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/511079
Maintenance of differentiated cells with laminins Oct 25, 2021 Issued
Array ( [id] => 17385920 [patent_doc_number] => 20220033772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-03 [patent_title] => FACTOR RICH PRODUCTS FROM UMBILICAL CORD MESENCHYMAL STEM CELLS [patent_app_type] => utility [patent_app_number] => 17/501775 [patent_app_country] => US [patent_app_date] => 2021-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6243 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 162 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17501775 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/501775
Lyophilized compositions containing umbilical cord lining stem cells conditioned medium Oct 13, 2021 Issued
Array ( [id] => 18787263 [patent_doc_number] => 20230375528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-23 [patent_title] => SCREENING METHOD FOR THE IDENTIFICATION OF NOVEL THERAPEUTIC COMPOUNDS [patent_app_type] => utility [patent_app_number] => 18/248022 [patent_app_country] => US [patent_app_date] => 2021-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17830 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18248022 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/248022
SCREENING METHOD FOR THE IDENTIFICATION OF NOVEL THERAPEUTIC COMPOUNDS Oct 5, 2021 Pending
Array ( [id] => 17382999 [patent_doc_number] => 20220030851 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-03 [patent_title] => MODULATING ISCHEMIC INJURY [patent_app_type] => utility [patent_app_number] => 17/494690 [patent_app_country] => US [patent_app_date] => 2021-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7334 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17494690 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/494690
MODULATING ISCHEMIC INJURY Oct 4, 2021 Pending
Menu